Literature DB >> 12547718

Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome.

Marta Sanchez-Carbayo1, Paola Capodieci, Carlos Cordon-Cardo.   

Abstract

The expression profiles of nine bladder cancer cell lines were compared against a pool containing equal total RNA quantities of each of them. Lower expression of KiSS-1 was revealed in cells derived from the most advanced bladder tumors. When comparing 15 primary bladder tumors versus a pool of four bladder cancer cell lines, lower transcript levels of KiSS-1 were observed in the invasive bladder carcinomas as compared to superficial tumors. KiSS-1 expression ratios provided prognostic information. The expression pattern of KiSS-1 transcripts was analyzed using in situ hybridization in nine bladder cancer cells, paired normal urothelium and bladder tumor samples (n = 25), and tissue microarrays of bladder tumors (n = 173). We observed complete loss of KiSS-1 in all invasive tumors under study as compared to their respective normal urothelium. The expression of KiSS-1 was found to be significantly associated with histopathological stage. Patients with lower KiSS-1 expression showed a direct correlation with overall survival in a subset of bladder tumors whose follow-up was available (n = 69). We did not observe any significant differential KiSS-1 expression along cell cycle by sorting analysis. A potential tumor suppressor role in bladder cancer was revealed for KiSS-1. Moreover, it showed predictive value by identifying patients with poor outcome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12547718      PMCID: PMC1851149          DOI: 10.1016/S0002-9440(10)63854-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  High-fidelity mRNA amplification for gene profiling.

Authors:  E Wang; L D Miller; G A Ohnmacht; E T Liu; F M Marincola
Journal:  Nat Biotechnol       Date:  2000-04       Impact factor: 54.908

2.  Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis.

Authors:  S H Koo; K C Kwon; C H Ihm; Y M Jeon; J W Park; C K Sul
Journal:  Cancer Genet Cytogenet       Date:  1999-04-15

3.  A novel, sensitive detection system for high-density microarrays using dendrimer technology.

Authors:  R L Stears; R C Getts; S R Gullans
Journal:  Physiol Genomics       Date:  2000-08-09       Impact factor: 3.107

4.  Patterns of chromosomal imbalances in muscle invasive bladder cancer.

Authors:  R Simon; H Burger; A Semjonow; L Hertle; H J Terpe; W Bocker
Journal:  Int J Oncol       Date:  2000-11       Impact factor: 5.650

5.  Systematic variation in gene expression patterns in human cancer cell lines.

Authors:  D T Ross; U Scherf; M B Eisen; C M Perou; C Rees; P Spellman; V Iyer; S S Jeffrey; M Van de Rijn; M Waltham; A Pergamenschikov; J C Lee; D Lashkari; D Shalon; T G Myers; J N Weinstein; D Botstein; P O Brown
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

6.  Changes in cadherin-catenin complexes in the progression of human bladder carcinoma.

Authors:  L A Giroldi; P P Bringuier; T Shimazui; K Jansen; J A Schalken
Journal:  Int J Cancer       Date:  1999-07-02       Impact factor: 7.396

7.  Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors.

Authors:  A Hoos; M J Urist; A Stojadinovic; S Mastorides; M E Dudas; D H Leung; D Kuo; M F Brennan; J J Lewis; C Cordon-Cardo
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

8.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.

Authors:  T R Golub; D K Slonim; P Tamayo; C Huard; M Gaasenbeek; J P Mesirov; H Coller; M L Loh; J R Downing; M A Caligiuri; C D Bloomfield; E S Lander
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

9.  KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation.

Authors:  C Yan; H Wang; D D Boyd
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

10.  Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor.

Authors:  T Ohtaki; Y Shintani; S Honda; H Matsumoto; A Hori; K Kanehashi; Y Terao; S Kumano; Y Takatsu; Y Masuda; Y Ishibashi; T Watanabe; M Asada; T Yamada; M Suenaga; C Kitada; S Usuki; T Kurokawa; H Onda; O Nishimura; M Fujino
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

View more
  57 in total

Review 1.  Kisspeptin signalling in the physiology and pathophysiology of the urogenital system.

Authors:  Fazal Wahab; Bibi Atika; Muhammad Shahab; Rüdiger Behr
Journal:  Nat Rev Urol       Date:  2015-12-01       Impact factor: 14.432

2.  KiSS-1 expression in human breast cancer.

Authors:  Tracey A Martin; Gareth Watkins; Wen G Jiang
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Aberrant methylated EDNRB can act as a potential diagnostic biomarker in sporadic colorectal cancer while KISS1 is controversial.

Authors:  Reza Mousavi Ardehaie; Shahriar Hashemzadeh; Shahin Behrouz Sharif; Morteza Ghojazadeh; Ladan Teimoori-Toolabi; Ebrahim Sakhinia
Journal:  Bioengineered       Date:  2017-01-31       Impact factor: 3.269

4.  Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system.

Authors:  E Votsi; D Roussos; I Katsikis; A Karkanaki; M Kita; D Panidis
Journal:  Hippokratia       Date:  2008       Impact factor: 0.471

5.  Adaptive history of single copy genes highly expressed in the term human placenta.

Authors:  Zhuocheng Hou; Roberto Romero; Monica Uddin; Nandor Gabor Than; Derek E Wildman
Journal:  Genomics       Date:  2008-11-05       Impact factor: 5.736

6.  Double-blind, randomized, placebo-controlled study of safety, tolerability, pharmacokinetics and pharmacodynamics of TAK-683, an investigational metastin analogue in healthy men.

Authors:  Graham Scott; Irfan Ahmad; Katy Howard; David MacLean; Cristina Oliva; Steve Warrington; Darren Wilbraham; Paul Worthington
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

7.  KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study.

Authors:  Katharina Schmid; Xiaowei Wang; Andrea Haitel; Wolfang Sieghart; Markus Peck-Radosavljevic; Martin Bodingbauer; Susanne Rasoul-Rockenschaub; Fritz Wrba
Journal:  Virchows Arch       Date:  2007-02       Impact factor: 4.064

8.  KISS1 receptor is preferentially expressed in clinically non-functioning pituitary tumors.

Authors:  Marianna Yaron; Ulrich Renner; Suzan Gilad; Günter K Stalla; Naftali Stern; Yona Greenman
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

9.  Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancer.

Authors:  Rou Wang; David S Morris; Scott A Tomlins; Robert J Lonigro; Alexander Tsodikov; Rohit Mehra; Thomas J Giordano; L Priya Kunju; Cheryl T Lee; Alon Z Weizer; Arul M Chinnaiyan
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

10.  Metastin has potential as a suitable biomarker and novel effective therapy for cancer metastasis (Review).

Authors:  Sunao Shoji; Xian Yang Tang; Haruhiro Sato; Yukio Usui; Toyoaki Uchida; Toshiro Terachi
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.